Clinical value of carbon nanoparticle staining in identifying metastatic lymph nodes in colorectal cancer surgery. PFS in anti-EGFR therapy depending on gene alteration.

Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...